Molecular Diagnosis and Management of Heart Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 2250
Special Issue Editors
Interests: cardiology; arrhythmia; congenital heart disease; dilated cardiomyopathy; coronary heart disease; evidence-based medicine; medical genetics; molecular pathogenesis; diagnosis; treatment
Interests: exercise; heart failure; non-coding RNA; exosomes
Interests: dilated cardiomyopathy; myocardial hypertrophy; heart failure; cardiac differentiation; heart development; single-cell RNA sequencing; epigenetics; regulatory network; bioinformatics
Special Issue Information
Dear Colleagues,
Heart disease, i.e., coronary heart disease, congenital heart disease, rheumatic heart disease, cardiac arrhythmia, cardiomyopathy, heart failure, etc., is a leading cause of substantial morbidity and mortality globally, and one of the most significant challenges in today’s world. Aggregating evidence has convincingly demonstrated that both environmental risk factors (unhealthy diet, physical inactivity, gestation, microbial infection, trauma, and exposure to toxicants) and genetic defects (genetic mutation, copy number variation, chromosomal abnormalities, and aneuploid) contribute to heart disease. Despite the striking progress in treatment, the incidence and prevalence of heart disease seem to be further increasing. Hence, early prevention, diagnosis and subsequently timely treatment are considered critical factors in reducing the mortality and morbidity of heart disease.
This Special Issue entitled “Molecular Diagnosis and Management of Heart Disease” focuses on the most recent and most pioneering advances in diagnosis, treatment, and prevention of heart disease, which occurs from the fetal period to adulthood.
We cordially invite you to submit your new articles, which could be original studies or reviews.
Dr. Yiqing Yang
Dr. Junjie Xiao
Dr. Li Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart disease
- diagnosis
- etiology
- mechanism
- treatment
- prevention
- epidemiology
- cardiac surgery
- cardiac intervention
- cardiac development
